Publication | Open Access
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
33
Citations
20
References
2024
Year
Adding marizomib to standard temozolomide-based radiochemotherapy resulted in more toxicity, but did not improve OS or PFS in patients with newly diagnosed glioblastoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1